Table 4.

Abnormal pathway activities in blood-derived CD4+ T cells from 10 patients with primary breast cancer (GSE36765) [19], using the normal pathway activity score (mean ± 2SD) as an upper threshold for the normal pathway activity. Pathway activities classified as abnormal are highlighted in gray.

	FOXO	NFκB	JAK-STAT1/2	JAK-STAT3	TGFβ	Notch
patient 1	8.5	17.4	−7.4	−2.4	−5.0	1.6
patient 2	−1.6	−1.5	−7.7	−7.3	−14.5	−5.7
patient 3	5.9	6.3	−8.7	−5.5	−14.7	−8.7
patient 4	−3.8	−5.1	−5.6	−6.2	−19.6	−6.1
patient 5	2.4	8.4	−8.7	−4.3	−11.7	−4.2
patient 6	1.7	5.9	−7.2	−6.3	−13.2	−8.4
patient 7	6.9	3.2	−8.3	−5.8	−14.3	−7.3
patient 8	1.3	5.2	−9.3	−6.7	−14.9	−6.8
patient 9	−2.5	−1.3	−4.2	−8.1	−18.4	−8.0
patient 10	−2.2	−3.6	−6.2	−7.3	−18.8	−8.4